Antimicrobial peptides: A new class of antimalarial drugs?

Frontiers in Pharmacology

Volumn 5, Issue DEC, 2014, Pages 275-

  Vale, Nuno ^a   Aguiar, Luísa ^a   Gomes, Paula ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

AMP; Amphipathic; Antimalarial; Antimicrobial; Cationic; Membranolytic; Peptide; Plasmodium spp

Indexed keywords

ADENOSINE PHOSPHATE; ANTIMALARIAL AGENT; ARGININE; ARTEMISININ; CECROPIN; CHLOROQUINE; CYSTEINE; DERMASEPTIN; DISULFIDE; GLYCINE; HISTIDINE; IDR 1018; MAGAININ DERIVATIVE; MELITTIN; NK 2; NVB 302; OMIGANAN; OP 145; PEXIGANAN; POLYPEPTIDE ANTIBIOTIC AGENT; PROLINE; TRYPSIN; UNCLASSIFIED DRUG;

AEDES AEGYPTI; ALPHA HELIX; ANOPHELES GAMBIAE; ANTIMALARIAL ACTIVITY; BRAIN MALARIA; DISEASE CARRIER; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; HYDROPHOBICITY; INFECTION PREVENTION; MALARIA; NONHUMAN; PLASMODIUM GALLINACEUM; PROTEIN SECONDARY STRUCTURE; REVIEW;

EID: 84921783790     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00275     Document Type: Review

References (150)

1. Achtman, A. H., Pilat, S., Law, C. W., Lynn, D. J., Janot, L., Mayer, M. L.,et al. (2012). Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria. Sci. Transl. Med. 4, 135ra164. doi: 10.1126/scitranslmed.3003515
2. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L.,et al. (2000). The human antimicrobial and chemotactic peptides ll-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
3. Andrä, J., and Leippe, M. (1999). Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin. Med. Microbiol. Immunol. 188, 117-124. doi: 10.1007/s004300050113
4. Anthony, L., and Freda, P. U. (2009). From somatostatin to octreotide LAR: evolution of a somatostatin analogue. Curr. Med. Res. Opin. 25, 2989-2999. doi: 10.1185/03007990903328959
5. Arrighi, R. B., Ebikeme, C., Jiang, Y., Ranford-Cartwright, L., Barrett, M. P., Langel, U.,et al. (2008). Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei. Antimicrob. Agents Chemother. 52, 3414-3417. doi: 10.1128/AAC.01450-07
6. Arrighi, R. B., Nakamura, C., Miyake, J., Hurd, H., and Burgess, J. G. (2002). Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias. Antimicrob. Agents Chemother. 46, 2104-2110. doi: 10.1128/AAC.46.7.2104-2110.2002
7. Bals, R., Wang, X., Zasloff, M., and Wilson, J. M. (1998). The peptide antibiotic ll-37/hcap-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. U.S.A. 95, 9541-9546. doi: 10.1073/pnas.95.16.9541
8. Bastos, M., Bai, G., Gomes, P., Andreu, D., Goormaghtigh, E., and Prieto, M. (2008). Energetics and partition of two cecropin-melittin hybrid peptides to model membranes of different composition. Biophys. J. 94, 2128-2141. doi: 10.1529/biophysj.107.119032
9. Bechinger, B. (1996). Towards membrane protein design: pH dependent topology of histidine-containing polypeptides. J. Mol. Biol. 263, 768-775. doi: 10.1006/jmbi.1996.0614
10. Becker, K., Tilley, L., Vennerstrom, J. L., Roberts, D., Rogerson, S., and Ginsburg, H. (2004). Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int. J. Parasitol. 34, 163-189. doi: 10.1016/j.ijpara.2003.09.011
11. Beevers, A. J., and Dixon, A. M. (2010). Helical membrane peptides to modulate cell function. Chem. Soc. Rev. 39, 2146-2157. doi: 10.1039/b912944h
12. Bell, A. (2011). Antimalarial peptides: the long and the short of it. Curr. Pharm. Des. 17, 2719-2731. doi: 10.2174/138161211797416057
13. Bell, A., Monaghan, P., and Page, A. P. (2006). Peptidyl-prolyl cis-trans isomerases (immunophilins) and their roles in parasite biochemistry, host-parasite interaction and antiparasitic drug action. Int. J. Parasitol. 36, 261-276. doi: 10.1016/j.ijpara.2005.11.003
14. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., and Tomita, M. (1992). Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121, 130-136. doi: 10.1016/0167-4838(92)90346-F
15. Biagini, G. A., O'Neill, P. M., Nzila, A., Ward, S. A., and Bray, P. G. (2003). Antimalarial chemotherapy: young guns or back to the future? Trends Parasitol. 19, 479-487. doi: 10.1016/j.pt.2003.09.011
16. Blackman, M. J. (2004). Proteases in host cell invasion by the malaria parasite. Cell. Microbiol. 6, 893-903. doi: 10.1111/j.1462-5822.2004.00437.x
17. Blandin, S., Moita, L. F., Kocher, T., Wilm, M., Kafatos, F. C., and Levashina, E. A. (2002). Reverse genetics in the mosquito Anopheles gambiae: targeted disruption of the defensin gene. EMBO Rep. 3, 852-856. doi: 10.1093/embo-reports/kvf180
18. Boddey, J. A., Carvalho, T. G., Hodder, A. N., Sargeant, T. J., Sleebs, B. E., Marapana, D.,et al. (2013). Role of Plasmepsin V in export of diverse protein families from the Plasmodium falciparum exportome. Traffic 14, 532-550. doi: 10.1111/tra.12053
19. Boman, H. G. (2003). Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254, 197-215. doi: 10.1046/j.1365-2796.2003.01228.x
20. Boman, H. G., Wade, D., Boman, I. A., Wahlin, B., and Merrifield, R. B. (1989). Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett. 259, 103-106. doi: 10.1016/0014-5793(89)81505-4
21. Borel, J. F., Baumann, G., Chapman, I., Donatsch, P., Fahr, A., Mueller, E. A.,et al. (1996). In vivo pharmacological effects of ciclosporin and some analogues. Adv. Pharmacol. 35, 115-246. doi: 10.1016/S1054-3589(08)60276-8
22. Bruston, F., Lacombe, C., Zimmermann, K., Piesse, C., Nicolas, P., and El Amri, C. (2007). Structural malleability of plasticins: preorganized conformations in solution and relevance for antimicrobial activity. Biopolymers 86, 42-56. doi: 10.1002/bip.20703
23. Bulet, P., Hetru, C., Dimarcq, J. L., and Hoffmann, D. (1999). Antimicrobial peptides in insects; structure and function. Dev. Comp. Immunol. 23, 329-344. doi: 10.1016/S0145-305X(99)00015-4
24. Carballar-Lejarazu, R., Rodriguez, M. H., de la Cruz Hernandez-Hernandez, F., Ramos-Castaneda, J., Possani, L. D., Zurita-Ortega, M.,et al. (2008). Recombinant scorpine: a multifunctional antimicrobial peptide with activity against different pathogens. Cell. Mol. Life Sci. 65, 3081-3092. doi: 10.1007/s00018-008-8250-8
25. Carlsson, A., Engstrom, P., Palva, E. T., and Bennich, H. (1991). Attacin, an antibacterial protein from Hyalophora cecropia, inhibits synthesis of outer membrane proteins in Escherichia coli by interfering with omp gene transcription. Infect. Immun. 59, 3040-3045.
26. Carlsson, A., Nystrom, T., de Cock, H., and Bennich, H. (1998). Attacin - an insect immune protein-binds lps and triggers the specific inhibition of bacterial outer-membrane protein synthesis. Microbiology 144, 2179-2188. doi: 10.1099/00221287-144-8-2179
27. Carter, V., Underhill, A., Baber, I., Sylla, L., Baby, M., Larget-Thiery, I.,et al. (2013). Killer bee molecules: antimicrobial peptides as effector molecules to target sporogonic stages of Plasmodium. PLoS Pathog. 9:e1003790. doi: 10.1371/journal.ppat.1003790
28. Castle, M., Nazarian, A., Yi, S. S., and Tempst, P. (1999). Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets. J. Biol. Chem. 274, 32555-32564. doi: 10.1074/jbc.274.46.32555
29. Christensen, B., Fink, J., Merrifield, R. B., and Mauzerall, D. (1988). Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc. Natl. Acad. Sci. U.S.A. 85, 5072-5076. doi: 10.1073/pnas.85.14.5072
30. Clough, B., Rangachari, K., Strath, M., Preiser, P. R., and Wilson, R. J. (1999). Antibiotic inhibitors of organellar protein synthesis in Plasmodium falciparum. Protist 150, 189-195. doi: 10.1016/S1434-4610(99)70021-0
31. Clough, B., Strath, M., Preiser, P., Denny, P., and Wilson, I. R. (1997). Thiostrepton binds to malarial plastid rRNA. FEBS Lett. 406, 123-125. doi: 10.1016/S0014-5793(97)00241-X
32. Collins, F. H., Sakai, R. K., Vernick, K. D., Paskewitz, S., Seeley, D. C., Miller, L. H.,et al. (1986). Genetic selection of a Plasmodium-refractory strain of the malaria vector Anopheles gambiae. Science 234, 607-610. doi: 10.1126/science.3532325
33. Conde, R., Zamudio, F. Z., Rodriguez, M. H., and Possani, L. D. (2000). Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett. 471, 165-168. doi: 10.1016/S0014-5793(00)01384-3
34. Costa, F., Carvalho, I. F., Montelaro, R. C., Gomes, P., and Martins, M. C. (2011). Covalent immobilization of Antimicrobial Peptides (AMPs) onto biomaterial surfaces. Acta Biomater. 7, 1431-1440. doi: 10.1016/j.actbio.2010.11.005
35. Cotter, P. D., Ross, R. P., and Hill, C. (2013). Bacteriocins - a viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95-105. doi: 10.1038/nrmicro2937
36. Craik, D. J., and Conibear, A. C. (2011). The chemistry of cyclotides. J. Org. Chem. 76, 4805-4817. doi: 10.1021/jo200520v
37. Craik, D. J., Daly, N. L., Bond, T., and Waine, C. (1999). Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J. Mol. Biol. 294, 1327-1336. doi: 10.1006/jmbi.1999.3383
38. Craik, D. J., Fairlie, D. P., Liras, S., and Price, D. (2013). The future of peptide-based drugs. Chem. Biol. Drug Des. 81, 136-147. doi: 10.1111/cbdd.12055
39. Dagan, A., Efron, L., Gaidukov, L., Mor, A., and Ginsburg, H. (2002). In Vitro Antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 46, 1059-1066. doi: 10.1128/AAC.46.4.1059-1066.2002
40. De Figueiredo, I. R., Freire, J. M., Flores, L., Veiga, A. S., and Castanho, M. A. (2014). Cell-penetrating peptides: a tool for effective delivery in gene-targeted therapies. IUBMB Life 66, 182-194. doi: 10.1002/iub.1257
41. Dhawan, S., Dua, M., Chishti, A. H., and Hanspal, M. (2003). Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells. J. Biol. Chem. 278, 30180-30186. doi: 10.1074/jbc. M305132200
42. Dixon, M. W., Thompson, J., Gardiner, D. L., and Trenholme, K. R. (2008). Sex in plasmodium: a sign of commitment. Trends Parasitol. 24, 168-175. doi: 10.1016/j.pt.2008.01.004
43. Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J.,et al. (2009). Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455-467. doi: 10.1056/NEJMoa0808859
44. Eckstein-Ludwig, U., Webb, R. J., Van Goethem, I. D., East, J. M., Lee, A. G., Kimura, M.,et al. (2003). Artemisinins target the SERCA of Plasmodium falciparum. Nature 424, 957-961. doi: 10.1038/nature01813
45. Efimova, S. S., Schagina, L. V., and Ostroumova, O. S. (2014). Channel-forming activity of cecropins in lipid bilayers: effect of agents modifying the membrane dipole potential. Langmuir 30, 7884-7892. doi: 10.1021/la501549v
46. Efron, L., Dagan, A., Gaidukov, L., Ginsburg, H., and Mor, A. (2002). Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J. Biol. Chem. 277, 24067-24072. doi: 10.1074/jbc. M202089200
47. Ekengren, S., and Hultmark, D. (1999). Drosophila cecropin as an antifungal agent. Insect Biochem. Mol. Biol. 29, 965-972. doi: 10.1016/S0965-1748(99)00071-5
48. Fjell, C. D., Hiss, J. A., Hancock, R. E., and Schneider, G. (2011). Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11, 37-51. doi: 10.1038/nrd3591
49. Flannery, E. L., Chatterjee, A. K., and Winzeler, E. A. (2013). Antimalarial drug discovery - approaches and progress towards new medicines. Nat. Rev. Microbiol. 11, 849-862. doi: 10.1038/nrmicro3138
50. Fox, J. L. (2013). Antimicrobial peptides stage a comeback. Nat. Biotechnol. 31, 379-382. doi: 10.1038/nbt.2572
51. Frederik, P. M., Stuart, M. C., Bomans, P. H., and Busing, W. M. (1989). Phospholipid, nature's own slide and cover slip for cryo-electron microscopy. J. Microsc. 153, 81-92. doi: 10.1111/j.1365-2818.1989.tb01469.x
52. Ganz, T., and Weiss, J. (1997). Antimicrobial peptides of phagocytes and epithelia. Semin. Hematol. 34, 343-354.
53. Gavigan, C. S., Kiely, S. P., Hirtzlin, J., and Bell, A. (2003). Cyclosporin-binding proteins of Plasmodium falciparum. Int. J. Parasitol. 33, 987-996. doi: 10.1016/S0020-7519(03)00125-5
54. Gavigan, C. S., Shen, M., Machado, S. G., and Bell, A. (2007). Influence of the Plasmodium falciparum P-glycoprotein homologue 1 (pfmdr1 gene product) on the antimalarial action of cyclosporin. J. Antimicrob. Chemother. 59, 197-203. doi: 10.1093/jac/dkl461
55. Ge, Y., MacDonald, D. L., Holroyd, K. J., Thornsberry, C., Wexler, H., and Zasloff, M. (1999). In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43, 782-788.
56. Gelhaus, C., Jacobs, T., Andra, J., and Leippe, M. (2008). The antimicrobial peptide NK-2, the core region of mammalian nk-lysin, kills intraerythrocytic Plasmodium falciparum. Antimicrob. Agents Chemother. 52, 1713-1720. doi: 10.1128/AAC.01342-07
57. Ghosh, J. K., Shaool, D., Guillaud, P., Ciceroni, L., Mazieri, D., Kustanovich, I.,et al. (1997). Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. J. Biol. Chem. 272, 31609-31616. doi: 10.1074/jbc.272.50.31609
58. Giordanetto, F., and Kihlberg, J. (2014). Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? J. Med. Chem. 57, 278-295. doi: 10.1021/jm400887j
59. González, C., Langdon, G. M., Bruix, M., Gálvez, A., Valdivia, E., Maqueda, M.,et al. (2000). Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin. Proc. Natl. Acad. Sci. U.S.A. 97, 11221-11226. doi: 10.1073/pnas.210301097
60. Gwadz, R. W., Kaslow, D., Lee, J. Y., Maloy, W. L., Zasloff, M., and Miller, L. H. (1989). Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitos. Infect. Immun. 57, 2628-2633.
61. Haney, E. F., and Hancock, R. E. W. (2013). Peptide design for antimicrobial and immunomodulatory applications. Biopolymers 100, 572-583. doi: 10.1002/bip.22250
62. Hsiao, L. L., Howard, R. J., Aikawa, M., and Taraschi, T. F. (1991). Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria parasite Plasmodium falciparum. Biochem. J. 274, 121-132.
63. Hsu, C. H., Chen, C., Jou, M. L., Lee, A. Y., Lin, Y. C., Yu, Y. P.,et al. (2005). Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res. 33, 4053-4064. doi: 10.1093/nar/gki725
64. Jacobs, T., Bruhn, H., Gaworski, I., Fleischer, B., and Leippe, M. (2003). NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi. Antimicrob. Agents Chemother. 47, 607-613. doi: 10.1128/AAC.47.2.607-613.2003
65. Jagadish, K., and Camarero, J. A. (2010). Cyclotides: a promising scaffold for peptide-based therapeutics. Biopolymers 94, 611-616. doi: 10.1002/bip.21433
66. Jaynes, J. M., Burton, C. A., Barr, S. B., Jeffers, G. W., Julian, G. R., White, K. L.,et al. (1988). In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB J. 2, 2878-2883.
67. Jeu, L., and Fung, H. B. (2004). Daptomycin: a cyclic lipopeptide antimicrobial agent. Clin. Ther. 2, 1728-1757. doi: 10.1016/j.clinthera.2004.11.014
68. Kanodia, S., Kumar, G., Rizzi, L., Pedretti, A., Hodder, A. N., Romeo, S.,et al. (2014). Synthetic peptides derived from the C-terminal 6 kDa region of Plasmodium falciparum SERA5 inhibit the enzyme activity and malaria parasite development. Biochim. Biophys. Acta 1840, 2765-2775. doi: 10.1016/j.bbagen.2014.04.013
69. Kaspar, A. A., and Reichert, J. M. (2013). Future directions for peptide therapeutics developments. Drug Discov. Today 18, 807-817. doi: 10.1016/j.drudis.2013.05.011
70. Katoh, T., Goto, Y., Reza, M. S., and Suga, H. (2011). Ribosomal synthesis of backbone macrocyclic peptides. Chem. Commun. 47, 9946-9958. doi: 10.1039/c1cc12647d
71. Kim, W., Koo, H., Richman, A. M., Seeley, D., Vizioli, J., Klocko, A. D.,et al. (2004). Ectopic expression of a cecropin transgene in the human malaria vector mosquito Anopheles gambiae (diptera: Culicidae): effects on susceptibility to Plasmodium. J. Med. Entomol. 41, 447-455. doi: 10.1603/0022-2585-41.3.447
72. Klein, E. Y. (2013). Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread. Int. J. Antimicrob. Agents 41, 311-317. doi: 10.1016/j.ijantimicag.2012.12.007
73. Kokoza, V., Ahmed, A., Shin, S. W., Okafor, N., Zou, Z., and Raikhel, A. S. (2010). Blocking of Plasmodium transmission by cooperative action of cecropin a and defensin a in transgenic Aedes aegypti mosquitoes. Proc. Natl. Acad. Sci. U.S.A. 107, 8111-8116. doi: 10.1073/pnas.1003056107
74. Krugliak, M., Feder, R., Zolotarev, V., Gaidukov, L., Dagan, A., Ginsburg, H.,et al. (2000). Antimalarial activities of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 44, 2442-2451. doi: 10.1128/AAC.44.9.2442-2451.2000
75. Kückelhaus, S. A. S., Leite, J. R., Muniz-Junqueira, M. I., Sampaio, R. N., Bloch, C. Jr., and Tosta, C. E. (2009). Antiplasmodial and antileishmanial activities of phylloseptin-1, an antimicrobial peptide from the skin secretion of Phyllomedusa azurea (Amphibia). Exp. Parasitol. 123, 11-16. doi: 10.1016/j.exppara.2009.05.002
76. Kumar, R., Musiyenko, A., and Barik, S. (2005). Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin. Mol. Biochem. Parasitol. 141, 29-37. doi: 10.1016/j.molbiopara.2005.01.012
77. Kuroda, K., and Gaputo, G. A. (2013). Antimicrobial polymers as synthetic mimics of host-defense peptides. Wiley Interdiscip. Rev. Nanomed. Nanobitechnol. 5, 49-66. doi: 10.1002/wnan.1199
78. Ladokhin, A. S., and White, S. H. (2001). Protein chemistry at membrane interfaces: non-additivity of electrostatic and hydrophobic interactions. J. Mol. Biol. 309, 543-552. doi: 10.1006/jmbi.2001.4684
79. Lawer, A., Tai, J., Jolliffe, K. A., Fletcher, S., Avery, V. M., and Hunter, L. (2014). Total synthesis and antiplasmodial activity of pohlianin C and analogues. Bioorg. Med. Chem. Lett. 24, 2645-2647. doi: 10.1016/j.bmcl.2014.04.071
80. Lawyer, C., Pai, S., Watabe, M., Borgia, P., Mashimo, T., Eagleton, L.,et al. (1996). Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides. FEBS Lett. 390, 95-98. doi: 10.1016/0014-5793(96)00637-0
81. Lax, R. (2010). The Future of Peptide Development in the Pharmaceutical Industry, Pharmanuacturing: the International Peptide Review. Available at: http://www.polypeptide.com/web/upload/medias/1401702726538c49464a6f5.pdf (assessed November 21, 2014).
82. Lax, R., and Meenan, C. (2012a). Challenges for Therapeutic Peptides Part 1: On the Inside, Looking Out, Innovations in Pharmaceutical Technology. Available at: http://www.polypeptide.com/web/upload/medias/1401702387538c47f367ccc.pdf (assessed November 21, 2014).
83. Lax, R., and Meenan, C. (2012b). Challenges for Therapeutic Peptides Part 2: Delivery Systems, Innovations in Pharmaceutical Technology. Available at: http://www.polypeptide.com/web/upload/medias/1401702335538c47bf450c4.pdf (assessed November 21, 2014).
84. Leavy, O. (2010). Therapeutic antibodies: past, present and future. Nat. Rev. Immunol. 10, 297. doi: 10.1038/nri2763
85. Leeson, P. (2012). Drug discovery: chemical beauty contest. Nature 481, 455-456. doi: 10.1038/481455a
86. Lehrer, R., Barton, A., Daher, K. A., Harwig, S. S. L., Ganz, T., and Selsted, M. E. (1989). Interaction of human defensins with Escherichia coli. J. Clin. Invest. 84, 553-561. doi: 10.1172/JCI114198
87. Lehrer, R. I., Cole, A. M., and Selsted, M. E. (2012). θ-defensins: cyclic peptides with endless potential. J. Biol. Chem. 287, 27014-27019. doi: 10.1074/jbc. R112.346098
88. Li, W. F., Ma, G. X., and Zhou, X. X. (2006). Apidaecin-type peptides: biodiversity, structure-function relationships and mode of action. Peptides 27, 2350-2359. doi: 10.1016/j.peptides.2006.03.016
89. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25. doi: 10.1016/S0169-409X(96)00423-1
90. López-Rojas, R., Docobo-Pérez, F., Pachón-Ibáñez, M., De La Torre, B. G., Fernández-Reyes, M., March, C.,et al. (2011). Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 11, 1391-1398. doi: 10.1007/s10096-011-1233-y
91. Lowenberger, C. (2001). Innate immune response of Aedes aegypti. Insect Biochem. Mol. Biol. 31, 219-229. doi: 10.1016/S0965-1748(00)00141-7
92. Lowenberger, C., Bulet, P., Charlet, M., Hetru, C., Hodgeman, B., Christensen, B. M.,et al. (1995). Insect immunity: isolation of 3 novel inducible antibacterial defensins from the vector mosquito, Aedes aegypti. Insect Biochem. Mol. 25, 867-873. doi: 10.1016/0965-1748(95)00043-U
93. Lowenberger, C., Charlet, M., Vizioli, J., Kamal, S., Richman, A., Christensen, B. M.,et al. (1999). Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti. J. Biol. Chem. 274, 20092-20097. doi: 10.1074/jbc.274.29.20092
94. Ludtke, S. J., He, K., Heller, W. T., Harroun, T. A., Yang, L., and Huang, H. W. (1996). Membrane pores induced by magainin. Biochemistry 35, 13723-13728. doi: 10.1021/bi9620621
95. Maia, F. R., Barbosa, M., Gomes, D. B., Vale, N., Granja, P., Gomes, P.,et al. (2014). Hydrogel depots for local co-delivery of osteoinductive peptides and mesenchymal stem cells. J. Control. Release 189, 158-168. doi: 10.1016/j.jconrel.2014.06.030
96. Malpede, B. M., and Tolia, N. H. (2014). Malaria adhesins: structure and function. Cell. Microbiol. 16, 621-631. doi: 10.1111/cmi.12276
97. Mantel, P.-Y., Hoang, A. N., Goldowitz, I., Potashnikova, D., Hamza, B., Vorobjev, I.,et al. (2013). Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. Cell Host Microbe 13, 521-534. doi: 10.1016/j.chom.2013.04.009
98. Mason, A. J., Moussaoui, W., Abdelrahman, T., Boukhari, A., Bertani, P., Marquette, A.,et al. (2009). Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. J. Biol. Chem. 284, 119-133. doi: 10.1074/jbc. M806201200
99. Matsuda, S., and Koyasu, S. (2000). Mechanisms of action of cyclosporin. Immunopharmacology 47, 119-125. doi: 10.1016/S0162-3109(00)00192-2
100. McConkey, G. A., Rogers, M. J., and McCutchan, T. F. (1997). Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid like organelle with thiostrepton. J. Biol. Chem. 272, 2046-2049. doi: 10.1074/jbc.272.4.2046
101. Melo, M. N., Ferre, R., and Castanho, M. A. (2009). Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat. Rev. Microbiol. 7, 245-250. doi: 10.1038/nrmicro2095
102. Nickell, S. P., Scheibel, L. W., and Cole, G. A. (1982). Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Infect. Immun. 37, 1093-1100.
103. Otvos, L. Jr. (2005). Antibacterial peptides and proteins with multiple cellular targets. J. Pept. Sci. 11, 697-706. doi: 10.1002/psc.698
104. Pelegrini, P., Sarto, R., Silva, O., Franco, O. L., and Grossi-de-Sa, M. F. (2011). Antibacterial peptides from plants: what they are and how they probably work. Biochem. Res. Int. 2011, 1-9. doi: 10.1155/2011/250349
105. Philips, R. S. (2001). Current status of malaria and potential for control. Clin. Microbiol. Rev. 14, 208-226. doi: 10.1128/CMR.14.1.208-226.2001
106. Portmann, C., Sieber, S., Wirthensohn, S., Blom, J. F., Da Silva, L., Baudat, E.,et al. (2014). Balgacyclamides, antiplasmodial heterocyclic peptides from Microcystis aeruguinosa EAWAG 251. J. Nat. Prod. 77, 557-562. doi: 10.1021/np400814w
107. Possani, L. D., Corona, M., Zurita, M., and Rodríguez, M. H. (2002). From noxiustoxin to scorpine and possible transgenic mosquitoes resistant to malaria. Arch. Med. Res. 33, 398-404. doi: 10.1016/S0188-4409(02)00370-3
108. Pouny, Y., Rapaport, D., Mor, A., Nicolas, P., and Shai, Y. (1992). Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 31, 12416-12423. doi: 10.1021/bi00164a017
109. Powers, J.-P. S., and Hancock, R. E. W. (2003). The relationship between peptide structure and antibacterial activity. Peptides 24, 1681-1691. doi: 10.1016/j.peptides.2003.08.023
110. Pretzel, J., Mohring, F., Rahlfs, S., and Becker, K. (2013). Antiparasitic peptides. Adv. Biochem. Eng. Biotechnol. 135, 157-192. doi: 10.1007/10_2013_191
111. Prudêncio, M., Rodriguez, A., and Mota, M. M. (2006). The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol. 4, 849-856. doi: 10.1038/nrmicro1529
112. Pushpanathan, M., Gunasekaran, P., and Rajendhran, J. (2013). Antimicrobial peptides: versatile biological properties. Int. J. Pept. 2013:675391. doi: 10.1155/2013/675391
113. Raghuraman, H., and Chattopadhyay, A. (2007). Melittin: a membrane-active peptide with diverse functions. Biosci. Rep. 27, 189-223. doi: 10.1007/s10540-006-9030-z
114. Regev-Rudzki, N., Wilson, D. W., Carvalho, T. G., Sisquella, X., Coleman, B. M., Rug, M.,et al. (2013). Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. Cell 153, 1120-1133. doi: 10.1016/j.cell.2013.04.029
115. Robert, A., Dechy-Cabaret, O., Cazelles, J., and Meunier, B. (2002). From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Acc. Chem. Res. 35, 167-174. doi: 10.1021/ar990164o
116. Rodriguez, M. D. C., Zamudio, F., Torres, J. A., Gonzalez-Ceron, L., Possani, L. D., and Rodriguez, M. H. (1995). Effect of a cecropin-like synthetic ppetide (Shiva-3) on the sporogonic development of Plasmodium berghei. Exp. Parasitol. 80, 596-604. doi: 10.1006/expr.1995.1075
117. Rotem, S., and Mor, A. (2009). Antimicrobial peptide mimics for improved therapeutic properties. Biochim. Biophys. Acta 1788, 1582-1592. doi: 10.1016/j.bbamem.2008.10.020
118. Schoof, S., Pradel, G., Aminake, M. N., Ellinger, B., Baumann, S., Potowski, M.,et al. (2010). Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action. Angew. Chem. Int. Ed. Engl. 49, 3317-3321. doi: 10.1002/anie.200906988
119. Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W., and Lehrer, R. I. (1985). Primary structures of three human neutrophil defensins. J. Clin. Invest. 76, 1436-1439. doi: 10.1172/JCI112121
120. Sgolastra, F., Deronde, B. M., Sarapas, J. M., Som, A., and Tew, G. N. (2013). Designing mimics of membrane active proteins. Acc. Chem. Res. 46, 2977-2987. doi: 10.1021/ar400066v
121. Simmaco, M., Mignogna, G., and Barra, D. (1999). Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47, 435-450. doi: 10.1002/(SICI)1097-0282 (1998)47:6<435::AID-BIP3>3.0.CO;2-8
122. Singh, B., and Daneshvar, C. (2013). Human infections and detection of Plasmodium knowlesi. Clin. Microbiol. Rev. 26, 165-184. doi: 10.1128/CMR.00079-12
123. Som, A., Vemparala, S., Ivanov, I., and Tew, G. N. (2008). Synthetic mimics of antimicrobial peptides. Biopolymers 90, 83-92. doi: 10.1002/bip.20970
124. Sorensen, O., Cowland, J. B., Askaa, T., and Borregaard, N. (1997). An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J. Immunol. Methods 206, 53-59. doi: 10.1016/S0022-1759(97)00084-7
125. Sullivan, D. J. Jr., Gluzman, I. Y., Russell, D. G., and Goldberg, D. E. (1996). On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. U.S.A. 93, 11865-11870. doi: 10.1073/pnas.93.21.11865
126. Tanaka, H., Ishibashi, J., Fujita, K., Nakajima, Y., Sagisaka, A., Tomimoto, K.,et al. (2008). A genome-wide analysis of genes and gene families involved in innate immunity of Bombyx mori. Insect Biochem. Mol. Biol. 38, 1087-1110. doi: 10.1016/j.ibmb.2008.09.001
127. Teixeira, C., Vale, N., Pérez, B., Gomes, A., Gomes, J. R. B., and Gomes, P. (2014). "Recycling" classical drugs for malaria. Chem. Rev. 114, 11164-11220. doi: 10.1021/cr500123g
128. Tian, C., Gao, B., Rodriguez, M. C., Lanz-Mendoza, H., Ma, B., and Zhu, S. (2008). Gene expression, antiparasitic activity, and functional evolution of the drosomycin family. Mol. Immunol. 45, 3909-3916. doi: 10.1016/j.molimm.2008.06.025
129. Vale, N., Moreira, R., and Gomes, P. (2009). Primaquine revisited six decades after its discovery. Eur. J. Med. Chem. 44, 937-953. doi: 10.1016/j.ejmech.2008.08.011
130. van Kan, E. J., Demel, R. A., Breukink, E., van der Bent, A., and de Kruijff, B. (2002). Clananin permeabilizes target membranes via two distinctly different pH-dependent mechanisms. Biochemistry 18, 7529-7539. doi: 10.1021/bi012162t
131. Vijay, S., Rawat, M., Adak, T., Dixit, R., Nanda, N., Srivastava, H.,et al. (2011). Parasite killing in malaria non-vector mosquito Anopheles culicifacies species b: implication of nitric oxide synthase upregulation. PLoS ONE 6:e18400. doi: 10.1371/journal.pone.0018400
132. Vila-Perelló, M., and Andreu, D. (2005). Characterization and structural role of disulfide bonds in a highly knotted thionin from Pyrularia pubera. Biopolymers 80, 697-707. doi: 10.1002/bip.20270
133. Visser, B. J., van Vugt, M., and Grobusch, M. P. (2014). Malaria: an update on current chemotherapy. Expert Opin. Pharmacother. 15, 2219-1154. doi: 10.1517/14656566.2014.944499
134. Vizioli, J., Bulet, P., Charlet, M., Lowenberger, C., Blass, C., Muller, H. M.,et al. (2000). Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae. Insect Mol. Biol. 9, 75-84. doi: 10.1046/j.1365-2583.2000.00164.x
135. Vizioli, J., Bulet, P., Hoffmann, J. A., Kafatos, F. C., Muller, H. M., and Dimopoulos, G. (2001). Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae. Proc. Natl. Acad. Sci. U.S.A. 98, 12630-12635. doi: 10.1073/pnas.221466798
136. Wang, G., Li, X., and Wang, Z. (2009). APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 37, D933-D937. doi: 10.1093/nar/gkn823
137. Wang, S., Ghosh, A. K., Bongio, N., Stebbings, K. A., Lampe, D. J., and Jacobs-Lorena, M. (2012). Fighting malaria with engineered symbiotic bacteria from vector mosquitoes. Proc. Natl. Acad. Sci. U.S.A. 109, 12734-12739. doi: 10.1073/pnas.1204158109
138. Wang, Z., and Wang, G. (2004). APD: The antimicrobial peptide database. Nucleic Acids Res. 32, D520-D592. doi: 10.1093/nar/gkh025
139. Wegscheid-Gerlach, C., Gerber, H. D., and Diederich, W. E. (2010). Proteases of Plasmodium falciparum as potential drug targets and inhibitors thereof. Curr. Top. Med. Chem. 10, 346-367. doi: 10.2174/156802610790725461
140. Wei, S.-Y., Wu, J.-M., Kuo, Y.-Y., Chen, H.-L., Yip, B.-S., Tzeng, S.-R.,et al. (2006). Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. J. Bacteriol. 188, 328-334. doi: 10.1128/JB.188.1.328-334.2006
141. Wells, T. M., and Poll, E. M. (2010). When is enough enough? The need for a robust pipeline of high-quality antimalarials. Discov. Med. 9, 389-398.
142. White, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., and Dondorp, A. M. (2014). Malaria. Lancet 383, 723-735. doi: 10.1016/S0140-6736(13)60024-0
143. WHO. (2012). World Malaria Report. Geneva: World Health Organization.
144. Wieczorek, M., Jenssen, H., Kindrachuk, J., Scott, W. R. P., Elliott, M., Hilpert, K.,et al. (2010). Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem. Biol. 17, 970-980. doi: 10.1016/j.chembiol.2010.07.007
145. Wimley, W. C., Selsted, M. E., and White, S. H. (1994). Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci. 3, 1362-1373. doi: 10.1002/pro.5560030902
146. Yang, L., Harroun, T. A., Weiss, T. M., Ding, L., and Huang, H. W. (2001). Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 81, 1475-1485. doi: 10.1016/S0006-3495(01)75802-X
147. Yeaman, M. R., and Yount, N. Y. (2003). Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55, 27-55. doi: 10.1124/pr.55.1.2
148. Yi, H. Y., Chowdhury, M., Huang, Y. D., and Yu, X. Q. (2014). Insect antimicrobial peptides and their applications. Appl. Microbiol. Biotechnol. 98, 5807-5822. doi: 10.1007/s00253-014-5792-6
149. Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 84, 5449-5453. doi: 10.1073/pnas.84.15.5449
150. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395. doi: 10.1038/415389a